A Study to Explore the Long-Term Safety of TEV-48125 for the Prevention of Cluster Headache
Condition: Cluster Headache Intervention: Drug: Fremanezumab Sponsor: Teva Branded Pharmaceutical Products, R&D Inc. Enrolling by invitation – verified July 2017 Source: ClinicalTrials.gov Listing of Cluster Headache trials This is a 68-week study to evaluate the long-term safety of fremanezumab in patients with CH. Patients who complete the pivotal studies and enroll into the currentRead More →